YieldMax MRNA Option Income Strategy ETF
Limited financial coverage for MRNY.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.
- IPO
- 2023
- HQ
- Los Angeles, CA, US
Price Chart
- Market Cap
- $132.08M
- Div Yield
- 73.03%
- 52W High
- $27.50
- 52W Low
- $13.60
- 50D MA
- $16.59
- 200D MA
- $17.27
- Beta
- -0.18
- Avg Volume
- 186.93K
Get TickerSpark's AI analysis on MRNY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MRNY coverage
Recent articles, reports, and earnings notes.
No research on MRNY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRNY report →Similar companies
Peers in the same neighborhood.